tiprankstipranks
Ember Therapeutics Inc (EMBT)
OTHER OTC:EMBT
US Market

Ember Therapeutics (EMBT) Stock Price & Analysis

4 Followers

EMBT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.03 - $0.40
Previous Close$0.21
Volume200.00
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$2.30K
Total Debt (Recent Filing)$214.62K
Price to Earnings (P/E)
Beta1.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,707,500
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation1.13
R-Squared0.02
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

EMBT FAQ

What was Ember Therapeutics Inc’s price range in the past 12 months?
Ember Therapeutics Inc lowest stock price was $0.03 and its highest was $0.40 in the past 12 months.
    What is Ember Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Ember Therapeutics Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Ember Therapeutics Inc’s earnings last quarter?
    Currently, no data Available
    Is Ember Therapeutics Inc overvalued?
    According to Wall Street analysts Ember Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Ember Therapeutics Inc pay dividends?
      Ember Therapeutics Inc does not currently pay dividends.
      What is Ember Therapeutics Inc’s EPS estimate?
      Ember Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Ember Therapeutics Inc have?
      Ember Therapeutics Inc has 3,985,000 shares outstanding.
        What happened to Ember Therapeutics Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Ember Therapeutics Inc?
        Currently, no hedge funds are holding shares in EMBT
        ---

        Ember Therapeutics Stock Smart Score

        10
        Unlock Smart Score
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Company Description

        Ember Therapeutics Inc

        Ember Therapeutics Inc is engaged in the healthcare sector. It is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies. It looks to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Curis
        Krystal Biotech
        Repligen
        Repare Therapeutics
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis